BB Biotech AG
BION
Rangering i aksjer
#4521
BB Biotech AG is an investment fund overseen by Bellevue Asset Management AG.... BB Biotech AG is an investment fund overseen by Bellevue Asset Management AG. This fund allocates capital to publicly traded companies worldwide, with a primary focus on firms pioneering modern biotechnology, specifically in the development of medications and diagnostic tools. The construction of its investment portfolio is guided by a fundamental analysis approach. Established on November 9, 1993, BB Biotech AG is headquartered in Switzerland.
Aksjekurs
$61.04
Markedsverdi
$3.37B
Endring (1 dag)
-0.20%
Endring (1 år)
24.74%
Land
CH
Handel BB Biotech AG (BION)
Kategori
Financial Services
Aksjeprishistorikk for BB Biotech AG (BION)
Høyeste sluttskurs: $63.81 den 2026-10-01
Laveste sluttskurs: $15.30 den 2000-01-01
Laveste sluttskurs: $15.30 den 2000-01-01
Aksjeprishistorikk for BB Biotech AG fra 2000 til 2026
Årlig aksjeprisytelse
| År | Ytelse |
|---|---|
| 2026 (TTM) | 6.35% |
| 2025 | 38.69% |
| 2024 | -11.18% |
| 2023 | -24.95% |
| 2022 | -25.80% |
| 2021 | 2.69% |
| 2020 | 17.40% |
| 2019 | 11.01% |
| 2018 | -6.61% |
| 2017 | 23.80% |
| 2016 | -7.89% |
| 2015 | 22.59% |
| 2014 | 52.76% |
| 2013 | 62.77% |
| 2012 | 49.65% |
| 2011 | 1.37% |
| 2010 | -14.60% |
| 2009 | 29.73% |
| 2008 | -26.26% |
| 2007 | 3.29% |
| 2006 | 23.76% |
| 2005 | 1.84% |
| 2004 | 19.32% |
| 2003 | 21.32% |
| 2002 | -43.88% |
| 2001 | -30.37% |
| 2000 | 0.00% |
Aksjepris for lignende selskaper eller konkurrenter
| Selskap | Aksjepris | Endring 1år% | Land |
|---|---|---|---|
| $1.14K | 0.67% |
US
|
|
| $113.42 | -29.87% |
US
|
|
| $40.82 | 23.42% |
SE
|
|
| $91.46 | -25.82% |
US
|
|
| $46.56 | -13.76% |
US
|
